Related Experiment Video
Updated: Mar 3, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Takotsubo cardiomyopathy in amiodarone-induced hyperthyroidism
Ismael Capel1, Elisabet Tasa-Vinyals1, Albert Cano-Palomares1
1Endocrinology Department, Parc Taulí Sabadell University Hospital, Sabadell Barcelona, Spain.
Takotsubo cardiomyopathy (TC) can be triggered by amiodarone-induced hyperthyroidism, a rare cause distinct from emotional stress. This case highlights the importance of considering iatrogenic factors in TC development.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Takotsubo cardiomyopathy (TC), or 'broken heart syndrome,' is a reversible heart condition mimicking myocardial infarction.
- While emotional trauma is a classic trigger, other factors like thyroid dysfunction and iatrogenic causes are increasingly recognized.
- Thyroid disease is a common comorbidity in TC patients, with both hyperthyroidism and hypothyroidism linked to its development.
Purpose of the Study:
- To report a unique case of TC precipitated by amiodarone-induced hyperthyroidism.
- To highlight the potential iatrogenic and endocrine triggers of TC beyond emotional stress.
- To emphasize the clinical significance of monitoring thyroid function in patients treated with amiodarone.
Main Methods:
- Case report of a postmenopausal female diagnosed with TC.
- Investigation revealed amiodarone-induced hyperthyroidism as the precipitating factor.
- Clinical, analytical, and electrocardiographic data were used for diagnosis.
Main Results:
- The patient presented with symptoms consistent with TC.
- Amiodarone-induced hyperthyroidism (Type II) was identified as the cause.
- This represents a rare instance of TC triggered by this specific iatrogenic endocrine condition.
Conclusions:
- Amiodarone-induced hyperthyroidism can precipitate Takotsubo cardiomyopathy.
- Clinicians should consider iatrogenic causes, particularly thyroid dysfunction from amiodarone, in TC diagnosis.
- Given amiodarone's widespread use for atrial fibrillation, awareness of this risk is crucial.
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure Drugs: Inotropic Agents
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis III: Medical Management

